Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
GenEmbryomics provides comprehensive preimplantation genetic screening of IVF embryos using whole genome sequencing, screening for chromosome abnormalities, mosaicism, and thousands of inherited and new genetic mutations. It serves patients and families undergoing IVF, delivering reports to help select embryos with the lowest genetic disease risk.
2 investors
GenePath Diagnostics is a molecular diagnostics company offering laboratory tests and assays for infectious diseases, cancers, and genetic disorders to medical professionals and patients. Established in India, the company provides rapid and sensitive molecular testing solutions positioned as more accessible and affordable than conventional diagnostic methods.
2 investors
2 investors
Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
2 investors
Genesis Therapeutics applies artificial intelligence to discover and develop drugs for challenging targets, combining machine learning with biotech research. It operates in the AI-driven drug discovery space.
2 investors
GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.
2 investors
Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS. The company's gene scissors technology offers advantages in gene editing efficiency and delivery compared to existing approaches.
2 investors
Genobank provides a platform for patients to own, control, and monetize their genomic data through blockchain-linked biosamples and AI-powered bioinformatics workflows. The platform enables patients to share their biological data with researchers and clinical trials while maintaining transparency and earning potential from data licensing.
2 investors
LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.
2 investors
Genomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
2 investors
Genvax Technologies develops mRNA and nanoparticle-based vaccines for livestock, focusing on custom, herd-specific formulations that aim to improve speed and precision compared to conventional vaccine platforms. The company serves animal health and food supply sectors.
2 investors
Gerostate Alpha creates drug candidates targeting age-related conditions and long-term illnesses.
2 investors
A pharmaceutical company whose executive team emphasizes innovation and patient care.
2 investors
Giftshed builds a single-cell cancer data platform that images billions of cells from whole blood, uses Vision AI and robotics to detect and isolate rare circulating tumor cells, and applies single-cell RNA sequencing and multi-omics to guide precision cancer therapy. The platform is aimed at personalized cancer diagnostics and metastatic biology research.
2 investors
Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY dissolving on the tongue to activate brain regions regulating food intake and metabolism. Its treatments target obesity, type 2 diabetes, and associated cardiometabolic disorders.
2 investors
Giraffe Bio develops custom biomolecules that recover metals from low-grade ores and mining waste, serving mining companies with a drop-in technology that improves recovery rates while reducing water, energy, and chemical consumption. The company currently focuses on copper and lithium extraction with plans to expand into gold, nickel, rare earth elements, and other critical minerals.
2 investors
Gisens Biotech develops G-LoC, a portable graphene-based biochip technology that delivers rapid health monitoring and diagnostic test results from home samples in minutes rather than days. The company's initial product, KF4+, is designed for patients with chronic kidney disease to perform comprehensive kidney function testing at home with results integrated into electronic health records.
2 investors
Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.
2 investors
Baltimore-based immunology company focused on treatments for cancer and autoimmune disorders; raised an $11.5 million Series C led by First In Ventures.
2 investors
Global Brains is a Japanese venture capital firm that invests across seed to late-stage startups, with particular focus on deep tech sectors including AI, climate tech, and healthcare alongside enterprise and commerce businesses.
2 investors
GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.
2 investors
GlycoX develops a food ingredient derived from a native plant oil that aims to reduce post-meal blood-sugar spikes and support metabolic health. It is positioned as a preventive, food-based approach to glucose control and longevity for everyday consumers.
2 investors
GOOD Meat produces cultivated chicken meat made from animal cells without animal slaughter, approved for sale in Singapore and the United States and available at select restaurants. The company is a brand of Eat Just, Inc., which also produces plant-based egg products.
2 investors
Portfolio company acquired by Roche.
2 investors